Repare Therapeutics (RPTX) Earnings Date & Reports

A.I. Advisor

published Earnings

RPTX is expected to report earnings to rise 5.93% to -86 cents per share on November 06

Repare Therapeutics RPTX Stock Earnings Reports

Q3'24

Est.

$-0.87

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.28

Q4'23

Missed

by $0.31

Q3'23

Beat

by $0.41

The last earnings report on August 06 showed earnings per share of -81 cents, beating the estimate of -87 cents. With 61.89K shares outstanding, the current market capitalization sits at 139.65M.

View a ticker or compare two or three

Compare

RPTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RPTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RPTX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

7210 Frederick-Banting Street

Phone

+1 857 412-7018

Employees

179

Web

https://www.reparerx.com